Esophagogastric Cancers
Showing 1 - 25 of 4,915
NSCLC, Cutaneous Melanoma, Carcinoma, Renal Cell Trial (KFA115, tislelizumab)
Recruiting
- Carcinoma, Non-Small-Cell Lung
- +10 more
-
Singapore, SingaporeNovartis Investigative Site
Nov 16, 2022
Esophageal Cancer, Esophagogastric Junction Cancer Trial in Worldwide (Autologous genetically modified ADP-A2M4CD8 cells)
Recruiting
- Esophageal Cancer
- Esophagogastric Junction Cancer
- Autologous genetically modified ADP-A2M4CD8 cells
-
Duarte, California
- +33 more
Aug 23, 2022
Oncology, Melanoma, Ovarian Cancer Trial in United States (E-602, Pembrolizumab)
Recruiting
- Oncology
- +16 more
- E-602
- Pembrolizumab
-
Grand Rapids, Michigan
- +4 more
May 27, 2022
Esophagogastric Cancer Trial in Toronto (PET-MRI)
Recruiting
- Esophagogastric Cancer
- PET-MRI
-
Toronto, Ontario, CanadaPrincess Margaret Cancer Centre
Apr 5, 2023
Esophageal Adenocarcinoma, Esophageal Cancer, HER-2 Protein Overexpression Trial in New York, Providence (Nivolumab, Trastuzumab
Not yet recruiting
- Esophageal Adenocarcinoma
- +3 more
- Nivolumab
- Trastuzumab deruxtecan
-
New York, New York
- +1 more
Jul 28, 2022
Esophagogastric Tumors, Gastric Cancer, Gastric Tumor Trial in United States (Trastuzumab, Pembrolizumab)
Recruiting
- Esophagogastric Tumors
- +9 more
-
Basking Ridge, New Jersey
- +6 more
Jul 8, 2022
Gastric Cancer, Colorectal Cancer, Pancreatic Cancer Trial in Pittsburgh (Tumor Infiltrating Lymphocytes (TIL), Fludarabine +
Recruiting
- Gastric Cancer
- +9 more
- Tumor Infiltrating Lymphocytes (TIL)
- Fludarabine + Cyclophosphamide combination
-
Pittsburgh, PennsylvaniaUPMC Hillman Cancer Center
Jul 21, 2022
Gastric Cancer, Cancer of the Stomach, Esophagogastric Junction Trial in Worldwide (BMS-986213, Nivolumab, XELOX)
Active, not recruiting
- Gastric Cancer
- +2 more
- BMS-986213
- +4 more
-
Clovis, California
- +77 more
Jan 9, 2023
Metastatic Breast Cancer Trial in New York (Tucatinib)
Recruiting
- Metastatic Breast Cancer
-
New York, New YorkMemorial Sloan Kettering Cancer Center
May 26, 2023
Gastric Cancer Trial in Beijing (Radical gastrectomy with dissection of lower mediastinal lymph node)
Recruiting
- Gastric Cancer
- Radical gastrectomy with dissection of lower mediastinal lymph node
-
Beijing, Beijing, ChinaBeijing Cancer Hospital
Nov 21, 2021
Gastric Cancer Trial in Australia, New Zealand (drug, radiation, procedure)
Active, not recruiting
- Gastric Cancer
- Epirubicin + cisplatin + 5-fluorouracil OR epirubicin + cisplatin + capecitabine OR epirubicin + oxaliplatin + capecitabine OR 5-Fluorouracil + leucovorin + oxaliplatin + docetaxel
- +2 more
-
Newcastle, New South Wales, Australia
- +22 more
Mar 21, 2022
Stomach Tumor, Gastrointestinal Tumors, Digestive System Tumor Trial in Havana (Ocoxin-Viusid®)
Recruiting
- Stomach Neoplasm
- +9 more
- Ocoxin-Viusid®
-
Havana, La Habana, CubaNational Institute of Oncology and Radiobiology (INOR)
Oct 20, 2021
Gastric Adenocarcinoma, Esophagogastric Junction, Gastric Cancer Trial run by the National Cancer Institute (NCI) (Surgery,
Recruiting
- Gastric Adenocarcinoma
- +2 more
- Surgery
- +3 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Feb 2, 2023
Gastric, Colorectal Adenocarcinoma Trial in Shenyang (tislelizumab)
Not yet recruiting
- Gastric
- Colorectal Adenocarcinoma
-
Shenyang, Liaoning, ChinaLiaoning Cancer Hospital & Institute
Nov 1, 2023
Esophageal Cancer, Gastric Cancer Trial in Worldwide (Surveillance protocol)
Not yet recruiting
- Esophageal Cancer
- Gastric Cancer
- Surveillance protocol
-
Cologne, Germany
- +12 more
Oct 29, 2023
Acute Esophageal Variceal Hemorrhage Trial in Hanzhou (Growth Inhibitor)
Recruiting
- Acute Esophageal Variceal Hemorrhage
- Growth Inhibitor
-
Hanzhou, Zhejiang, China2nd Affiliated Hospital, School of Medicine, Zhejiang University
Aug 22, 2023
Gastric Adenocarcinoma Trial (cadonilimab combined +paclitaxel (albumin-bound))
Not yet recruiting
- Gastric Adenocarcinoma
- cadonilimab combined +paclitaxel (albumin-bound)
- (no location specified)
Nov 1, 2023
Esophagogastric Adenocarcinoma Trial (Sacituzumab govitecan)
Not yet recruiting
- Esophagogastric Adenocarcinoma
- Sacituzumab govitecan
- (no location specified)
Nov 9, 2023
Esophageal Cancer, Gastric Adenocarcinoma, HER2 Gene Mutation Trial in United States (Pembrolizumab, Trastuzumab)
Not yet recruiting
- Esophageal Cancer
- +2 more
-
Baltimore, Maryland
- +8 more
Nov 3, 2023
The Diagnostic Dilemma of Anastomotic Leak in Esophagogastric
Completed
- Anastomotic Leak
- Esophageal and gastric resections requiring an anastomosis
-
Singapore, SingaporeNational University Hospital
Oct 21, 2022
Anastomotic Leak Esophagus Trial (Obsidian)
Not yet recruiting
- Anastomotic Leak Esophagus
- Obsidian
- (no location specified)
Feb 1, 2023
Siewert Type II Adenocarcinoma of Esophagogastric Junction Trial in Xi'an (Endoscopy Ivor-lewis, Laparoscopic transabdominal
Recruiting
- Siewert Type II Adenocarcinoma of Esophagogastric Junction
- Endoscopy Ivor-lewis
- Laparoscopic transabdominal enlarged gastrectomy
-
Xi'an, Shaanxi, ChinaLi
Jun 7, 2022
the Effect of Succinylcholine on Barrier Pressure Trial (Succinylcholine)
Completed
- the Effect of Succinylcholine on Barrier Pressure
- (no location specified)
Sep 23, 2022
Adenocarcinoma of the Stomach, Adenocarcinoma of Esophagogastric Junction, Epstein-Barr Virus-Associated Gastric Carcinoma Trial
Not yet recruiting
- Adenocarcinoma of the Stomach
- +2 more
- Toripalimab
- +2 more
-
Hangzhou, Zhejiang, China
- +7 more
Jul 25, 2023